BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21819320)

  • 1. Chronic hepatitis C infection and insulin resistance: two best friends.
    Abenavoli L; Almasio PL
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):555-8. PubMed ID: 21819320
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus-induced insulin resistance: not all genotypes are the same.
    Neuschwander-Tetri BA
    Gastroenterology; 2008 Feb; 134(2):619-22. PubMed ID: 18242225
    [No Abstract]   [Full Text] [Related]  

  • 3. Steatosis and chronic hepatitis C virus infection: mechanisms and significance.
    Patel K; Zekry A; McHutchison JG
    Clin Liver Dis; 2005 Aug; 9(3):399-410, vi. PubMed ID: 16023973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
    Basaranoglu M; Basaranoglu G
    World J Gastroenterol; 2011 Sep; 17(36):4055-62. PubMed ID: 22039318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and HCV: will new knowledge modify clinical management?
    Negro F
    J Hepatol; 2006 Oct; 45(4):514-9. PubMed ID: 16901576
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
    García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
    J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection.
    Puri P; Sanyal AJ
    Clin Liver Dis; 2006 Nov; 10(4):793-819. PubMed ID: 17164118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause-effect relationship between the hepatitis C virus and insulin resistance at the time of direct antiviral therapy.
    Negro F
    Gut; 2010 Dec; 59(12):1590-1. PubMed ID: 20926646
    [No Abstract]   [Full Text] [Related]  

  • 10. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathomechanism of metabolic disorders in HCV infection].
    Boroń-Kaczmarska A
    Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
    Bernsmeier C; Duong FH; Christen V; Pugnale P; Negro F; Terracciano L; Heim MH
    J Hepatol; 2008 Sep; 49(3):429-40. PubMed ID: 18486982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
    Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic hepatitis C, steatosis and insulin resistance--clinical implications].
    Lăcătuşu C; Mihai B; Graur M; Mihai C; Dranga M; Cijevschi-Prelipcean C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):306-15. PubMed ID: 21870716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and steatosis.
    Björnsson E; Angulo P
    Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities in chronic hepatitis C. Introduction.
    Capeau J; Gharakanian S; Younossi ZM
    Liver Int; 2009 Mar; 29 Suppl 2():1-2. PubMed ID: 19187072
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease.
    Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watababe S; Kubota S; Senda S; Masaki T
    Nutr Res; 2011 Nov; 31(11):829-35. PubMed ID: 22118753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.